Quick Answer
Pulmonx Corp reported Total Assets of $129.29 million for the year ending 2025.
- Pulmonx Corp showed a decrease of -20.6% in Total Assets from 2024 to 2025.
- This data is from Pulmonx Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $71.24 million | Q1 2021: $255.27 million | Q2 2021: $248.94 million | Q3 2021: $246.82 million | Q1 2022: $222.85 million | Q2 2022: $212.73 million | Q3 2022: $202.20 million | Q1 2023: $201.27 million | Q2 2023: $193.11 million | Q3 2023: $185.02 million | Q1 2024: $164.58 million | Q2 2024: $172.63 million | Q3 2024: $167.40 million | Q1 2025: $150.74 million | Q2 2025: $147.19 million | Q3 2025: $138.28 million.
- Over the full 7 years of available data (2019 to 2025), Pulmonx Corp's Total Assets has grown by 141.5%.
- Historical annual values: Fiscal year 2025: $129.29 million | Fiscal year 2024: $162.85 million | Fiscal year 2023: $177.78 million | Fiscal year 2022: $193.68 million | Fiscal year 2021: $235.17 million | Fiscal year 2020: $263.71 million | Fiscal year 2019: $53.53 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: